M. Bergholz

628 total citations
27 papers, 463 citations indexed

About

M. Bergholz is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, M. Bergholz has authored 27 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 5 papers in Genetics. Recurrent topics in M. Bergholz's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Vascular Tumors and Angiosarcomas (4 papers). M. Bergholz is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Vascular Tumors and Angiosarcomas (4 papers). M. Bergholz collaborates with scholars based in Germany, Austria and Kazakhstan. M. Bergholz's co-authors include Michael Kneba, G. Krieger, Hermann Herbst, H. Stein, Michael Hummel, T Finn, Gerald Niedobitek, Ioannis Anagnostopoulos, A. Schauer and Stefan Beissert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer and International Journal of Cancer.

In The Last Decade

M. Bergholz

21 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Bergholz Germany 10 264 225 107 85 76 27 463
A Horstman Netherlands 15 431 1.6× 409 1.8× 177 1.7× 84 1.0× 92 1.2× 18 619
G Delsol France 10 218 0.8× 138 0.6× 68 0.6× 64 0.8× 67 0.9× 26 407
Francesca Monardo Italy 10 223 0.8× 170 0.8× 152 1.4× 60 0.7× 63 0.8× 20 466
Cedith M. Copenhaver United States 11 200 0.8× 212 0.9× 87 0.8× 33 0.4× 71 0.9× 12 424
Maria Andersson‐Anvret Sweden 12 405 1.5× 173 0.8× 90 0.8× 202 2.4× 60 0.8× 19 565
Jeffrey A. Schrager United States 7 237 0.9× 238 1.1× 216 2.0× 108 1.3× 66 0.9× 9 592
J Goldman United States 10 189 0.7× 160 0.7× 254 2.4× 40 0.5× 128 1.7× 14 642
A Puissant France 13 181 0.7× 189 0.8× 141 1.3× 48 0.6× 85 1.1× 42 641
Pascal Bourquard France 10 271 1.0× 197 0.9× 91 0.9× 47 0.6× 96 1.3× 19 530
Yoshihito Hayami Japan 13 154 0.6× 197 0.9× 161 1.5× 42 0.5× 169 2.2× 26 583

Countries citing papers authored by M. Bergholz

Since Specialization
Citations

This map shows the geographic impact of M. Bergholz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bergholz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bergholz more than expected).

Fields of papers citing papers by M. Bergholz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bergholz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bergholz. The network helps show where M. Bergholz may publish in the future.

Co-authorship network of co-authors of M. Bergholz

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bergholz. A scholar is included among the top collaborators of M. Bergholz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bergholz. M. Bergholz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergholz, M., et al.. (2008). Splenektomie bei Erwachsenen und das OPSI-Syndrom. DMW - Deutsche Medizinische Wochenschrift. 109(33). 1249–1254.
2.
Busch, Maike, et al.. (1993). [Management strategies for a Merkel cell tumor].. PubMed. 46(6). 196–9.
3.
Waase, Inge, M. Bergholz, Stefan Beissert, et al.. (1992). Heterogeneity of tumour necrosis factor production in renal cell carcinoma. European Journal of Cancer. 28(10). 1660–1664. 12 indexed citations
4.
Mäurer, J., et al.. (1992). [Case reports on the importance of the locoregional radiotherapy of Merkel cell tumor].. PubMed. 168(9). 536–40. 5 indexed citations
5.
Kneba, Michael, I Bolz, G. Krieger, et al.. (1991). Clinical characteristics of high-grade lymphomas with immune genes in germline configuration. Cancer. 67(3). 603–609. 12 indexed citations
6.
Kneba, Michael, Hermann Herbst, Christiane Pott, et al.. (1991). Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing.. PubMed. 51(12). 3243–50. 41 indexed citations
7.
Kneba, Michael, I Bolz, Hermann Herbst, et al.. (1990). Polymerase Chain Reaction Analysis of t(14;18) Junctional Regions in B-Cell Lymphomas. Leukemia & lymphoma. 3(2). 109–117. 8 indexed citations
8.
Kneba, Michael, et al.. (1990). Heterogeneity of immunoglobulin gene rearrangements in B‐cell lymphomas. International Journal of Cancer. 45(4). 609–613. 11 indexed citations
9.
Herbst, Hermann, Gerald Niedobitek, Michael Kneba, et al.. (1990). High incidence of Epstein-Barr virus genomes in Hodgkin's disease.. PubMed. 137(1). 13–8. 198 indexed citations
10.
Osmers, R., M. Bergholz, & W. Kühn. (1989). Vaginal sonographic visualisation of a cervical carcinoma. International Journal of Gynecology & Obstetrics. 28(3). 283–285. 2 indexed citations
11.
Prindull, G., et al.. (1987). CFU-F circulating in cord blood. Annals of Hematology. 54(6). 351–359. 21 indexed citations
12.
Brehler, Randolf, et al.. (1986). Immunhistochemische Untersuchungen zur Bestimmung des Hormonrezeptorstatus von Mammakarzinomen. Journal of Molecular Medicine. 64(8). 370–374. 3 indexed citations
13.
Bergholz, M., et al.. (1983). Toxisch-allergisches Lungenödem nach Cyclophosphamid- und Ifosfamid-Therapie. Oncology Research and Treatment. 6(2). 84–86. 5 indexed citations
14.
Bergholz, M., et al.. (1983). Overwhelming infection after splenectomy in spite of some spleen remaining and splenosis. Journal of Molecular Medicine. 61(21). 1075–1079. 22 indexed citations
15.
Bergholz, M., G. R. F. Krueger, & A. Schauer. (1982). Lethal cardio-respiratory failure in a case of progressive angioimmunoblastic lymphadenopathy (AIL). Pathology - Research and Practice. 173(4). 417–424.
16.
Bergholz, M., M. Altmannsberger, & A. Schauer. (1981). Benign mesothelioma of the cul-de-sac. A tumor with misleading histologie pattern in an unusual localization. Gynecologic Oncology. 11(3). 393–395. 2 indexed citations
17.
Krueger, G. R. F., M. Bergholz, Herbert Bartsch, R. Fischer, & A. Schauer. (1979). Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymphadenopathy (AIL). Journal of Cancer Research and Clinical Oncology. 95(1). 87–91. 12 indexed citations
18.
Bergholz, M., et al.. (1979). Krebsrisiko bei papill�ren Proliferationen der Brustdr�se. Langenbeck s Archives of Surgery. 348(3). 157–165.
19.
Bergholz, M., A. Schauer, & H. Poppe. (1979). Diagnostic and Differential Diagnostic Aspects in Histiocytosis X Diseases. Pathology - Research and Practice. 166(1). 59–71. 4 indexed citations
20.
Prauser, H. & M. Bergholz. (1974). Taxonomy of actinomycetes and screening for antibiotic substances.. PubMed. 28(4). 441–57. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026